About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: November 2011
Less is More – e-Advocacy in a New Budget Era
Early this fall, I wrote a blog posting on the growing role of e-advocacy. Notably covered was the growing use of social media not only by members of Congress (virtually all members are using Twitter, YouTube and/or Facebook) as a … Continue reading
Posted in Advocacy, Current Affairs
1 Comment
FDA Needs to Be Clear About Social Media
After an extended Thanksgiving break, there has been time to contemplate the upcoming end of the year. Two and a half years ago, the FDA stated that “it was not the medium, it was the message” to sum up its … Continue reading
Posted in FDA Image, FDA Policy, New and Social Media
11 Comments
New Study on U.S. Drug Shortages Calls for Establishment of Early Warning System
For some time now, there have been shortages in the supply of key drugs, many of which have been key treatments for patients undergoing therapy for extremely serious and life-threatening conditions. The FDA has developed a page on its website … Continue reading
Posted in Current Affairs, FDA Policy
1 Comment
Weekly Roundup 11/11/11
Our first snow fall is behind us. The palette of vivid colors that hung on the trees has begun to fade. The clock has fallen backward, meaning many of us are waking up earlier and tiring more quickly. It is … Continue reading
Posted in Weekly Roundup
Comments Off on Weekly Roundup 11/11/11
Will Pharma Embrace Google+?
The twittersphere was aflutter with the news yesterday that Google+ was now set up for branded pages. Until now, Google+ was set up for individuals to use, but companies not so much. For example, if a company went to set … Continue reading
Posted in New and Social Media
2 Comments